Naghmeh Satarzadeh | Biotechnology | Best Researcher Award

Posted on by Zoology Honour

Assist. Prof. Dr. Naghmeh Satarzadeh | Biotechnology | Best Researcher Award

Assistant Professor at Kerman University of Medical Sciences, Iran

Dr. Naghmeh Satarzadeh is a dynamic Iranian researcher and academic, currently pursuing her Ph.D. in Pharmaceutical Biotechnology at Kerman University of Medical Sciences. With a solid foundation in microbiology and biotechnology, her expertise spans across nanomedicine, phage therapy, and microbial applications in drug development. Over the years, she has made significant contributions to the field of biosynthesized nanoparticles and antibacterial agents, with multiple peer-reviewed publications. Naghmeh is also an active reviewer for prestigious international journals, showcasing her commitment to advancing scientific knowledge. Her passion for innovation is reflected in her award-winning research ideas and her involvement in commercializing health technologies. In addition to her research, she has taught several undergraduate and Pharm.D. courses, further underlining her dedication to education and mentorship. Known for her academic excellence and multidisciplinary approach, she continues to push the boundaries of science through collaboration, creativity, and resilience.

Professional Profiles📖

ORCID 

Education 🎓

Dr. Naghmeh Satarzadeh’s academic journey began with a B.Sc. in Microbiology from Islamic Azad University (2005–2009), where she developed a deep interest in microbial sciences. She pursued her M.Sc. in Microbial Biotechnology at Payam Noor University (2011–2013), gaining hands-on experience in applied microbiology and molecular techniques. In 2017, she embarked on her Ph.D. in Pharmaceutical Biotechnology at the Faculty of Pharmacy, Kerman University of Medical Sciences, where she has since distinguished herself through pioneering research in nanoparticle biosynthesis and phage technology. Her educational path is marked by a consistent pursuit of innovation, critical thinking, and academic excellence. Her achievements include top GPA among Ph.D. entrants and multiple recognitions for her research ideas and outputs. Dr. Satarzadeh’s formal training is complemented by her deep understanding of both fundamental biology and advanced biotechnological techniques, positioning her as a versatile scholar capable of translating science into impactful medical solutions.

Work Experience💼

Dr. Naghmeh Satarzadeh has cultivated a rich blend of academic, research, and teaching experience throughout her career. As a lecturer, she has taught various undergraduate and Pharm.D. courses, including Genetics Laboratory, Molecular Biology, and Biotechnology, shaping future generations of scientists. Her research experience includes extensive laboratory work in DNA extraction, nanoparticle synthesis, bacteriophage biology, and cytotoxicity analysis. She has led and co-authored over 20 scientific publications, many of which explore innovative biomedical applications of biosynthesized nanoparticles and phages. Dr. Satarzadeh is also a trusted peer reviewer for several leading journals such as BMC Microbiology, BioNanoScience, and Virology Journal, which speaks to her credibility in the scientific community. She has actively contributed to health technology innovation centers, bridging the gap between research and practical application. With a career grounded in interdisciplinary science and translational research, Dr. Satarzadeh continues to build impactful experiences that serve both academia and society.

Awards and Honors 🏆

Dr. Naghmeh Satarzadeh has been recognized multiple times for her outstanding academic performance and innovative contributions to biotechnology. In 2018, her research idea was selected for presentation at the First Pharmaceutical Technology Commercialization Festival in Dubai. She earned first place in both the 2020 Idea Talk Speech Competition and the 2021 national call for extremophile research proposals. Her scientific excellence was further acknowledged in 2022 and 2023 when she registered novel bacterial strains (Bacillus tequilensis ASFS1 and Brevundimonas vesicularis strain sataricum) in GenBank. In 2023, she achieved the highest GPA among Ph.D. entrants in her field and was named Outstanding Talent. She was also recognized by Kerman University’s Health Technology Incubator and awarded First Researcher by both the National Student Research Committee and the Faculty of Pharmacy. These accolades reflect her dedication to scientific innovation, academic leadership, and her ability to transform complex research into recognized contributions.

Skills💡

Dr. Satarzadeh is highly skilled in a wide range of laboratory techniques essential for modern biomedical research. Her molecular biology toolkit includes DNA extraction, PCR, multiplex PCR, PCR-RFLP, and SDS-PAGE. She has hands-on experience with electrophoresis, bacteriophage cultivation, and DNA sequencing. She is proficient in nanoparticle synthesis using both bacterial and herbal sources and in analyzing their bioactivity through cytotoxicity and antioxidant assays. Her expertise extends to microbial testing, HPLC, TLC, and FTIR spectroscopy. In cell biology, she works adeptly with cell culture systems and MTT assays. She is proficient in data analysis using SPSS and is adept with scientific software such as Endnote, Chromas, CodonCode, CLC Genomics, IRPal, and ChemDraw. Additionally, her skillset includes primer design and gene analysis using Gene Runner. These diverse capabilities enable her to conduct interdisciplinary research at the intersection of microbiology, nanotechnology, and pharmacology.

Research Focus 🔬

Dr. Naghmeh Satarzadeh’s research centers around microbial biotechnology, with a specialized focus on biosynthesized nanoparticles, phage therapy, and microbial agents for medical applications. Her work bridges microbiology and nanomedicine, leveraging bacteria and bacteriophages to synthesize metal nanoparticles with therapeutic properties, including anticancer, antibacterial, and antioxidant effects. She is particularly interested in extremophiles and their unique biochemical pathways for novel compound production. Her recent studies delve into the biomedical potential of selenium and arsenic nanostructures, immunoglobulin Y conjugation, and green synthesis using medicinal plants like Mentha pulegium. Dr. Satarzadeh also explores epigenetic interactions with nanomaterials and the role of microbial agents in combatting drug-resistant infections and viral diseases such as COVID-19. Her research stands out for its interdisciplinarity, combining molecular biology, pharmacology, and material science to develop sustainable, effective health solutions. She is passionate about translating lab-based discoveries into clinical and industrial applications for a healthier future.

Conclusion✅

Dr. Naghmeh Satarzadeh is a highly competitive and deserving candidate for the Best Researcher Award. Her multidisciplinary research contributions, peer recognition, and academic accomplishments collectively present a compelling case. While a few areas such as international engagement and commercialization can be enhanced, her overall profile aligns very well with the criteria typically valued for such an award. She exemplifies innovation, productivity, and academic service.

Publications Top Notes📚

COVID-19 (Coronavirus disease 2019): a new coronavirus disease

📑 Citations: 104

📅 Year: 2020

Mentha pulegium as a source of green synthesis of nanoparticles…

📑 Citations: 38

📅 Year: 2023

An insight into biofabrication of selenium nanostructures and their biomedical application

📑 Citations: 25

📅 Year: 2023

Medicinal and Therapeutic Properties of Ephedra

📑 Citations: 25

📅 Year: 2022

Facile microwave-assisted biosynthesis of arsenic nanoparticles…

📑 Citations: 21

📅 Year: 2023

Antimicrobial activity of Ephedra pachyclada methanol extract…

📑 Citations: 18

📅 Year: 2016

Association between VKORC1 gene polymorphism and warfarin dose…

📑 Citations: 14

📅 Year: 2020

A review on immunoglobulin Y (IgY) conjugated with metal nanoparticles…

📑 Citations: 13

📅 Year: 2023

Phage therapy as a glimmer of hope in surgical site infections

📑 Citations: 12

📅 Year: 2024

Synthesized arsenic nanoparticles and their biomedical potential: a review

📑 Citations: 10

📅 Year: 2024

The impact of COVID-19 on liver injury in various age groups

📑 Citations: 10

📅 Year: 2023

The use of phages for the biosynthesis of metal nanoparticles…

📑 Citations: 9

📅 Year: 2024

Purification and anticancer activity of iron oxide nanoparticles by Bacillus tequilensis

📑 Citations: 5

📅 Year: 2024

The use of Ephedra herbs in the treatment of COVID-19

📑 Citations: 5

📅 Year: 2023

The spread of carbapenemase genes in K. pneumoniae in Iran: A review

📑 Citations: 5

📅 Year: 2021

Mutuality of epigenetics and nanoparticles: two sides of a coin

📑 Citations: 4

📅 Year: 2024

Relationship between early childhood caries and lactose in breast milk

📑 Citations: 3

📅 Year: 2022

Biological applications of nanoparticles synthesized via Olea europaea

📑 Citations: 2

📅 Year: 2024

[Cu(dimethylbpy)₂Cl]PF₆ complex as an antibacterial agent

📑 Citations: 1

📅 Year: 2024

Hepatitis B and C infection in Jirof blood donors (2011–2016)

📑 Citations: 1

📅 Year: 2022

Lin Zhou | Diseases | Excellence in Innovation

Posted on by Zoology Honour

prof. Dr. Lin Zhou | Diseases | Excellence in Innovation

Dr  at Guangdong Pharmaceutical University, China

Lin Zhou is a distinguished professor in the Bioengineering Department at Guangdong Pharmaceutical University, China. With a strong background in carbohydrate engineering and fermentation technology, he has significantly contributed to the fields of bioactive substances, phytochemicals, and microbial metabolites. His research spans various biomedical applications, particularly in food science and chronic metabolic diseases. Having worked as a lecturer, associate professor, and professor at GDPU, he has led multiple national and industry-funded research projects. Lin Zhou’s expertise lies in antioxidant, anti-tumor, and anti-aging properties of bioactive substances. His scientific contributions are widely recognized, with numerous publications in high-impact journals. Apart from academia, he has experience in industrial fermentation engineering, reflecting his practical approach to biotechnology research. His work continues to influence advancements in pharmaceutical and food sciences, earning him prestigious awards in science and technology.

Professional Profiles📖

ORCID

Education 🎓

Ph.D. in Carbohydrate Engineering (2006) – South China University of Technology (SCUT), Guangzhou, China, under the guidance of Prof. Siyuan Guo.

Master to Ph.D. Direct Track (2001-2006) – South China University of Technology.

B.S. in Fermentation Engineering (1995-1999) – Hubei University of Technology (HBUT).

Work Experience💼

2018-2019 – Visiting Scholar, CSIRO, Melbourne, Australia.

2014-2017 – Postdoctoral Researcher, South China University of Technology.

2006-Present – Professor, Guangdong Pharmaceutical University.

2011-2012 – Scientific Special Commissioner, Guangdong Province.

2000-2001 – Workshop Manager, HeChengFeng Food and Beverage Ltd, China.

1999-2000 – Workshop Manager, ChuTe Food and Beverage Ltd, China.

Awards and Honors 🏆

First Prize in Science and Technology (2024) – Provincial High-Tech Enterprise Association, Guangdong, China.

Second Prize in Science and Technology (2024) – Provincial Light Industry Council, Guangdong, China.

Skills 💡

Bioactive Compound Analysis

Fermentation Technology

Microbial Metabolite Research

Pharmaceutical Biotechnology

Food Science and Engineering

Scientific Writing and Research Management

Innovation in Biopharmaceuticals

Research Focus 🔬

Lin Zhou specializes in the functional study of bioactive substances, emphasizing phytochemicals and microbial metabolites. His research explores the antioxidant, anti-tumor, and anti-aging potential of natural compounds, contributing to biomedical sciences. His work intersects microbiology, food science, and pharmaceuticals, leading industry-oriented research and collaborations. He has participated in China’s National Key R&D Program and led multiple industry-funded projects, making significant contributions to applied biotechnology.

Conclusion✅

Prof. Lin Zhou is a strong candidate for the Excellence in Innovation Award due to his extensive contributions to bioengineering, pharmaceutical sciences, and food biotechnology. His research has significantly advanced knowledge in metabolic disease treatment and bioactive substances, making him a worthy recipient of this recognition. Enhancing commercialization efforts and expanding global collaborations could further elevate his profile in scientific innovation.

Publications Top Notes📚

“Piggyback Crowdsensing (PCS): Energy Efficient Crowdsourcing of Mobile Sensor Data by Exploiting Smartphone App Opportunities”
Citations: 224
Year: 2013

“Cutting the Cord: A Robust Wireless Facilities Network for Data Centers”
Citations: 83
Year: 2014

“On the Validity of Geosocial Mobility Traces”
Citations: 78
Year: 2013

“Voting by Committees”
Citations: 435
Year: 1991

“On a Conjecture by Gale About One-Sided Matching Problems”
Citations: 357
Year: 1990

“A New Bargaining Set of an N-Person Game and Endogenous Coalition Formation”
Citations: 174
Year: 1994

“Atomic-Scale Characterization of Dilute Dopants in Topological Insulators via STEM–EDS Using Registration and Cell Averaging Techniques”
Year: 2024

“Sub-Lexical Phonological and Semantic Processing of Semantic Radicals: A Primed Naming Study”
Citations: 57
Year: 2013

“A Chinese Text Input Brain–Computer Interface Based on the P300 Speller”
Citations: 50
Year: 2012

“Pre-Lexical Phonological Processing in Reading Chinese Characters: An ERP Study”
Citations: 36
Year: 2014

“Measuring Megaregional Structure in the Pearl River Delta by Mobile Phone Signaling Data: A Complex Network Approach”
Citations: 76
Year: 2020

“Actors and Network in the Marketization of Rural Collectively-Owned Commercial Construction Land (RCOCCL) in China: A Pilot Case of Langfa, Beijing”
Citations: 31
Year: 2020

“Efficiency and Equality of the Multimodal Travel Between Public Transit and Bike-Sharing Accounting for Multiscale”
Citations: 10
Year: 2024